Celyad SA (CYAD) Announces Receipt of U.S. Patent Related to Allogeneic TCR-Deficient CAR T-Cells Production
Tweet Send to a Friend
Celyad (Nasdaq: CYAD) announced the issuance of United States Patent No. 9,273,283 (“US Patent 9,273,283”) relating to a method of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
